Cepheid investor relations

Cepheid investor relations

Cepheid investor relations. Our patients-first mindset and spirit of innovation have helped us achieve record-breaking company growth—and the contributions of our associates play a vital role in our success and position as a global marketplace leader. com Nov 14, 2013 · Cepheid Investor Relations. 00. No webcast. 05/14/2024. Its systems automate traditional nucleic acid tests (tests for specific sequences of DNA or RNA ). Send a message. Website: www. Sunnyvale, CA 94089. 408-400-8329 [email protected] Mar 1, 2011 · For Cepheid Media Inquiries: For Cepheid Investor Inquiries: Jared Tipton. Sep 19, 2023. cepheid reports third quarter revenue of $44. We're elevating our breakthroughs in a bold new way on Pfizer. 0000000000. m. — October 1, 2014— Cepheid (NASDAQ: CPHD) today announced that, effective today, it has entered into a purchase agreement to acquire the customer relationships from its former distribution partner, the Laboratory Supply Company (LABSCO). 3616 shares of Cepheid common stock per $1,000 principal amount of notes (which is subject to adjustment in certain Selecting a year value will change the news content. Speaker: Seifi Ghasemi. 408-400-8329 [email protected] [email protected] Jul 13, 2010 · Cepheid Investor Relations. Sunnyvale, CA. , Aug. – September 6, 2016 — Cepheid (NASDAQ: CPHD) today announced that it has entered into a definitive agreement with Danaher Corporation (NYSE: DHR) under which Danaher will acquire all of the outstanding shares of Cepheid common stock for $53 per share in cash, or a total enterprise value of 16 hours ago · Ms. 20037 Telephone: (202) 828-0850 Fax: (202) 828-0860 FOR THOSE CEPHEID SHAREHOLDERS WHO NEED INFORMATION ABOUT RECEIVING THEIR MERGER CONSIDERATION, CONTACT Computershare, Inc. Farrell an option to purchase 100,000 shares of Cepheid common stock at the closing price of Cepheid common stock on Mr. Select Year: cepheid announces preliminary 2012 third quarter revenue results Xpert ® Cartridge Backorders to Ship in October, Full Year Revenue Guidance Unchanged SUNNYVALE, California, September 26, 2012 – Cepheid (Nasdaq: CPHD) today announced preliminary revenue results for the 2012 Third Quarter, ending September 30, 2012. Apr 11, 2011 · For Cepheid Investor Inquiries: Jared Tipton. 408-400-8329 [email protected] SOURCE Cepheid. 09. com Email: Disneyshareholder@computershare. 541. The company s systems enable rapid, sophisticated genetic testing for organisms and genetic-based In connection with his employment, the Compensation Committee of Cepheid’s Board of Directors has granted Mr. 0-0000. 408-400-8329 [email protected] Aug 6, 2012 · Cepheid Investor Relations. 00-2. dolore magna aliqua. Sunnyvale, CA 94089 . Miller will continue to serve as Cepheid's CFO through Feb 29, 2024 · A Guide to our New Product Pipeline Visualization. Aug 28, 2013 · For Cepheid Investor Inquiries: Jared Tipton. , July 29, 2014 / PRNewswire / -- With the recent completion of a record shipment of 774 GeneXpert systems to a single country in one quarter, Cepheid (Nasdaq: CPHD) today applauded groundbreaking tuberculosis programs in China where more than a million new cases of tuberculosis (TB) are reported each year. Cepheid’s respiratory testing revenue of ~$550M was above our expectation of ~$450M driven by higher volume and greater mix of 4-in-1 vs. 1 billion, or $1. Fax: (408) 541-4192 : CEPHEID TO OFFER $250 MILLION Feb 2, 2024 · AutoZone to Release Third Quarter Fiscal 2024 Earnings May 21, 2024. Toll Free: (800) 568-3476 Jun 16, 2014 · For Cepheid Investor Inquiries: Jared Tipton . 35pm Q&A 3. Miller will continue to serve as Cepheid's Feb 28, 2011 · For Cepheid Media Inquiries: For Cepheid Investor Inquiries: Jared Tipton. By. SUNNYVALE, CALIF. 277 Park Avenue New York, NY 10172-0003 212-270-2479 JPMCinvestorrelations@jpmchase. 5, 2015 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that Andrew Miller, executive vice president and chief financial officer, will be leaving Cepheid to pursue an opportunity with PTC Inc. , is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. , Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. 05-3. Fax: (408) 541 4192 : CEPHEID REPORTS FOURTH QUARTER Mar 24, 2015 · For Cepheid Media Inquiries: For Cepheid Investor Inquiries: Jared Tipton . Tel: (408) 400-8329 [email protected] SOURCE Cepheid. COVID Vx/Tx revenue was ~$30M. Toggle Summary. Acquires Customer Relationships from Former Distribution Partner . Q1. AutoZone 2nd Quarter Total Company Same Store Sales Increase 1. , Suite 800W Washington, D. FOR All OTHER INVESTOR INQUIRIES CONTACT DANAHER INVESTOR RELATIONS: http://investors. Cepheid . or by dialing +1 203-518-9765 outside the U. Outside the U. Based in Sunnyvale, Calif. Fitzgerald an option to purchase 56,000 shares of Cepheid common stock at the closing price of Cepheid common stock on Mr. 9 million GeneXpert ® System Momentum Drives 71% Year-Over-Year Growth in Core Clinical Business SUNNYVALE, California, October 28, 2008 – Cepheid (Nasdaq: CPHD) today reported revenue for the third quarter of 2008 of $44. Tel: (408) 400 8329 [email protected] [email protected] SOURCE Cepheid. , June 9, 2014 / PRNewswire / -- Cepheid (Nasdaq: CPHD) today announced that it has appointed Mr. 408-400-8329 [email protected] Dec 23, 2010 · Cepheid (Nasdaq: CPHD) today announced that its executives will be speaking at the following investor conference, and invited investors to participate via webcast. Appian's Vishal Hanjan Recognized with StateScoop 50 Award for Industry Leadership. 4192 CEPHEID REPORTS 2010 FIRST Oct 24, 2016 · For Cepheid Media & Investor Inquiries: Jacquie Ross, CFA +1 408-400-8329 [email protected] For Public Relations; For IR & Compliance; For Agency; For Small Business; All Products; About. 40-3. Daniel Feb 14, 2013 · Cepheid : Announces Board of Directors Changes. Feb 12, 2013 · SUNNYVALE, Calif. The notes will have an initial conversion rate of 15. cepheid reports 2014 third quarter results Commercial Clinical Grows 23% Driven by 25% Growth in Xpert Tests SUNNYVALE, California, October 16, 2014 – Cepheid (Nasdaq: CPHD) today reported revenues for the third quarter of 2014 of $115. 55pm Closing Thomas Schinecker, CEO Diagnostics 3. Telephone: (408) 541 4191. 6 million, representing growth of 24% from $106. 0% FX -0. Title. com Cepheid Investor Relations. Cepheid Announces Closing of CEPHEID EXTENDS REACH OF DIRECT US COMMERCIAL OPERATIONS . 10. Net earnings were $1. As a reminder, Cepheid’s Commercial Clinical revenue contributes a higher gross margin than the Company’s HBDC revenue. , Cepheid is a leading molecular diagnostics company that is an operating company within Danaher Corporation's Diagnostics platform. Watch these videos to learn about our company culture, to hear 16 hours ago · Air Products at Seaport Research Partners Growth Discovery Conference. Feb 3, 2011 · CONTACTS: For Cepheid Media Inquiries: For Cepheid Investor Inquiries: Jared Tipton Jacquie Ross Cepheid Corporate Communications Cepheid Investor Relations 408-400-8377 408-400-8329 communications@cepheid. 5% non-GAAP base business core revenue decline. May 17, 2024 at 3:00 PM EDT. , Jan. com Nov 28, 2012 · Cepheid Investor Relations. Earnings Supplement. Jacquie Ross - Vice President, Investor Relations. Non-GAAP core revenue decreased 11. Cepheid Welcomes Executive Vice President of Global Operations . 5%, including a 4. Peter Farrell to the position of Executive Vice President of International Commercial Operations. Guided by a digital-first approach, data-driven insights and white-label technology, we deliver growth for some of the world’s most recognized brands through a comprehensive product suite, while also offering direct-to-consumer solutions that give customers more Sep 19, 2023 · Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for tuberculosis (TB) at Cepheid's cost of $7. Toll Free: 1 (800) 546-5141. 9 million, an increase of 24% over the third quarter of fiscal 2007. For ADA-related inquiries, please contact Mar 10, 2012 · This paper discusses two aspects of current research on the Cepheid period-luminosity (P-L) relation: the derivation of mid-infrared (MIR) P-L relations and the investigation of multi-phase P-L relations. 4,972 As of 2022. Philippe Jacon is transitioning to the role of President of HBDC, replacing Paul Steuperaert who will now focus on our business in Jun 9, 2014 · Cepheid Investor Relations. Fax: (408) 541-4192 . 4192 CEPHEID EXPANDS LEADERSHIP TEAM WITH APPOINTMENT OF EXECUTIVE investor. Danaher and Veralto to Webcast Investor and Analyst Meeting. disneyshareholder. 904 Caribbean Drive . Vice President, Investor Relations. 35-3. Diagnostic Equipment. com Apr 7, 2010 · For Cepheid Investor Inquiries: Jared Tipton. 14, 2013 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that its Board of Directors has elected John Bishop as Chairman of the Board of Directors and named Cristina Kepner as Lead Independent Director, effective February 12, 2013. 408-400-8329 [email protected] Computershare Investor Services PO BOX 43013 Providence, RI 02940-3013. Telephone: (408) 541-4191 . February 14, 2013 at 04:10 pm EST. 408-400-8377. J. bagamery Cepheid . Cepheid [a] is an American molecular diagnostics company that is a wholly owned subsidiary of Danaher Corporation. Investors. 5, 2015 / PRNewswire / -- Cepheid (Nasdaq: CPHD) today announced that Andrew Miller, executive vice president and chief financial officer, will be leaving Cepheid to pursue an opportunity with PTC Inc. Nov 4, 2016 · Vice President, Investor Relations Danaher Corporation 2200 Pennsylvania Avenue, N. Farrell’s commencement date and restricted stock units in respect of 10,106 shares of Cepheid common stock. Q1 Adjusted OP margins of 30. 000. Upon conversion, the notes may be settled in shares of Cepheid common stock, cash or a combination of cash and shares of Cepheid common stock, at Cepheid’s election. Feb 28, 2011 · Cepheid Investor Relations. , a Massachusetts -based technology solutions provider. Headquartered in Sunnyvale, California, Cepheid will Miller will continue to serve as Cepheid’s CFO through February 3, 2015, directing Cepheid’s financial operations and assisting with the upcoming transition. Date. Air Products at BMO’s 2024 Chemicals @ Farm to Market Conference. May 7, 2015 · SUNNYVALE, Calif. investor. Fax: 408. Feb 1, 2012 · /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to Second Quarter 2023 Performance Summary $7,751 $7,157 Q222022Q222023 $2. SUNNYVALE, Calif. Tel: (408) 400 8377. Q2. 1 million for the third quarter of 2013. 408-400-8329 [email Jan 6, 2010 · CONTACTS: For Media Inquiries: For Cepheid Investor Inquiries: ----- ----- Jared Tipton Jacquie Ross Cepheid Corporate Communications Cepheid Investor Relations 408-400-8377 408-400-8329 [email Aug 21, 2015 · Cepheid Announces CFO Change SUNNYVALE, Calif. P. Apr 22, 2024 · Investor Relations. Jul 29, 2016 · Cepheid (NASDAQ:CPHD) Q2 2016 Earnings Call July 28, 2016 5:00 PM ETExecutives. Jan 5, 2015 · Cepheid CFO Resigns. 8, 2013 /PRNewswire/ -- Ahead of its presentation at the JP Morgan Healthcare Conference in San Francisco later today, Cepheid (Nasdaq: CPHD) this morning shared an update on Xpert test availability, highlighting that significant progress towards a return to normal manufacturing operations was achieved despite higher than anticipated demand for a number of Xpert test Jul 31, 2014 · Cepheid Investor Relations. Overnight Mail: Computershare Investor Services 150 Royall Street Suite 101 Canton, MA 02021 Oct 7, 2010 · For Cepheid Investor Inquiries: Jared Tipton. 6, 2016 / PRNewswire / -- Danaher Corporation (NYSE:DHR) ("Danaher" or the "Company") announced today that it has entered into a definitive merger agreement with Cepheid (NASDAQ:CPHD) pursuant to which Danaher will acquire all of the outstanding Developer of diagnostic systems focused to improve patient outcomes by enabling access to molecular testing. com investor. Revenues decreased 10. 5% Throughout this presentation, with respect to revenue performance, for the definitions of "Acquisitions," “Core,” and “FX,” please refer to the accompanying information required by Regulation G, located at the end of this presentation and on the "Investors investor. WASHINGTON, Sept. 40pm 2. Bishop - Chairman & Chief Executive Officer. Daskal will assume responsibility for worldwide finance operations, information technology, and investor relations. 00pm Welcome Karl Mahler, Head of investor Relations and Roche Group Planning 3 investor. Cepheid Corporate Communications. Check out our new visualized product pipeline, where you'll be able to take a deep dive into our working innovations and see where each product is in development! Find out more. Dec 27, 2012 · For Cepheid Investor Inquiries: Jared Tipton. Speaker: Sidd Manjeshwar. 36. Madden most recently served as Vice President Finance and Investor Relations, Vice President, Corporate Jul 29, 2014 · SUNNYVALE, Calif. Apr 15, 2015 · For Cepheid Investor Inquiries: Jacquie Ross, CFA. 408-400-8329 [email protected] Nov 5, 2012 · About Cepheid. Cepheid has disclosed that in 2016 it expects to generate $618 to $635 million in revenues. ET start and telling the operator that you are dialing in for Danaher's earnings conference call (Conference ID: DHRQ422). Cepheid Corporate Communications . 05 Q2 022Q2 023-25. 20037 Telephone: (202) 828-0850 Fax: (202) 828-0860. To receive future distributions of our Annual Report and Proxy by electronic delivery, please contact our transfer agent, Computershare. Tel: (408) 400-8329. 10pm 3. com. 9 million for the first quarter of 2014. The Global Fund is the Nov 5, 2012 · For Media Inquiries: For Investor Inquiries: ----- ----- Jared Tipton Jacquie Ross, CFA Cepheid Corporate Communications Cepheid Investor Relations Tel: (408) 400 8377 Tel: (408) 400 8329 communications@cepheid. 13, 2015 /PRNewswire/ Mr. Aug 31, 2023. 408-400-8329 [email protected] CEPHEID AGREES TO BE ACQUIRED BY DANAHER CORPORATION FOR $53 PER SHARE IN CASH . Jun 19, 2014 · For Cepheid Media Inquiries: For Cepheid Investor Inquiries: Jared Tipton. May 9, 2015 · Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost. 89. The company. 4 billion. jared. 408-400-8377 . 10-3. Presentation. Toll Free: (800) 568-3476 Dec 23, 2010 · Advanced search Log in Cepheid, a Danaher operating company, offers a broad array of comprehensive, competitive benefit programs that add value to our lives. Executives. Mr. 0% year-over-year to $6. Connecting members with knowledge, solutions and expertise that accelerate performance to ensure they deliver exceptional, cost-effective healthcare. With extensive investment advice, asset management and insurance capabilities and a nationwide network of more than 10,000 financial advisors, we have the strength and Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif. Tel: (408) 400 8329 [email protected] SOURCE Cepheid. 408-400-8329 For Public Relations; For IR & Compliance; For Agency; For Small Business; All Products; About. 904 Caribbean Drive. 7%-7. Jan 18, 2024 · About Cepheid Based in Sunnyvale, Calif. Jacquie Ross. Press Release. The tests can be used to identify and analyze pathogens and genetic disorders. Bishop - Chairman & Chief Executive Officer Apr 7, 2015 · SUNNYVALE, Calif. SOURCE Cepheid Exhibit 99. 97 each to the Global Fund to Fight AIDS, TB and Malaria ("the Global Fund") and to less-developed countries eligible for Cepheid's Global Access Program1 to support greater access to high-quality TB testing. You’ll receive annual materials immediately after publishing, help protect the environment, reduce Danaher’s printing and postage costs, and you can opt in or out at any time. Jacquie Ross, CFA. 408-400-8377 [email protected] Jacquie Ross. com : Cepheid. Gugino Vice President, Investor Relations Danaher Corporation 2200 Pennsylvania Avenue, N. 4191 . 8, 2013 /PRNewswire/ -- Ahead of its presentation at the JP Morgan Healthcare Conference in San Francisco later today, Cepheid (Nasdaq: CPHD) this morning shared an update on Xpert test availability, highlighting that significant progress towards a return to normal manufacturing operations was achieved despite higher Jul 30, 2014 · Cepheid Corporate Communications. Ilan Daskal to the position of Executive Vice President and Chief Financial Officer, effective April 9, 2015. . 14, 2013 / PRNewswire / -- Cepheid (Nasdaq: CPHD) today announced that its Board of Directors has elected John Bishop as Chairman of the Board of Directors and named Cristina Kepner as Lead Independent Director, effective February 12, 2013. 76 $2. Based on preliminary analysis, and given the revenue mix in the fourth quarter, the Company currently expects to report bottom line results just above the upper end of its previously-announced guidance ranges. Sep 6, 2016 · Danaher To Acquire Cepheid For $53. Form 10-Q / 10-K. FOR THOSE CEPHEID SHAREHOLDERS WHO NEED INFORMATION ABOUT RECEIVING THEIR MERGER CONSIDERATION, CONTACT: Computershare, Inc. Telephone: 408. Jan 30, 2024 · Key Fourth Quarter 2023 Results. 55-4. S. 5%; Domestic Same Store Sales Increase 0. Cepheid Investor Relations. 408-400-8329. Appian Named a Leader in the 2024 Gartner® Magic Quadrant™ for Process Mining Platforms Report. Non-GAAP Recs. Sep 3, 2014 · For Cepheid Investor Inquiries: Jacquie Ross, CFA Cepheid Investor Relations 408-400-8329 [email protected] SOURCE Cepheid. By automating highly complex and time-consuming manual procedures, the company's solutions Jan 8, 2013 · SUNNYVALE, Calif. 05pm 3. Fitzgerald's employment commencement date and restricted stock units in respect of 10,000 shares of Cepheid Birgit Masjost, Investor Relations Officer, & speaker panel Break 2. Jun 9, 2014 · SUNNYVALE, Calif. FOR THOSE CEPHEID SHAREHOLDERS WHO NEED INFORMATION ABOUT RECEIVING THEIR MERGER CONSIDERATION, CONTACT Computershare, Inc. Group purchasing organization serving academic medical centers, pediatric facilities, community hospitals, and nonacute health care providers. 408-400-8329 [email protected] May 2, 2023 · Cepheid’s strong results are a testament to the significant value and unique combination of fast, accurate lab quality results and the best-in-class workflow provides clinicians. Feb 02, 2024. Ameriprise Financial is a leading diversified financial services firm with a proud, 130-year legacy of helping clients achieve their financial goals. Q1 Adjusted EPS of $2. John L. 50 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $2. COVID-only tests. C. Edward Chung, Investor Relations 510-741-6104 ir Jun 8, 2010 · For Cepheid Investor Inquiries: Jared Tipton. com/contact. W. Phone: 1-855-553-4763 Toll: 1-781-575-3335. 3%; EPS Increases to $28. tipton@cepheid. 5% Core -7. Bishop, currently Cepheid's Chief Executive Officer, succeeds Thomas Gutshall Jan 5, 2015 · SUNNYVALE, Calif. : +1-781-575-2765. , April 7, 2015 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that it has appointed Mr. 00 Per Share, Or Approximately $4 Billion. Jan 8, 2013 · SUNNYVALE, Calif. 4191 Fax: 408. Jacquie Ross - Vice President, Investor Relations John L. 8% exceeded expectations. 408-400-8329 [email protected] Feb 14, 2013 · Cepheid Investor Relations. May 16, 2024 · Bread Financial is a tech-forward financial services company offering simple, personalized payment, lending and saving solutions. communications@cepheid. Request Printed Annual Report. danaher. , Feb. com For FIND: Krisztina Bagamery Scientific Communications Officer +41 22 749 29 41 krisztina. “We appreciate Andy’s many contributions to Cepheid’s growth over the last seven years, in particular the strong financial team he has built,” said John Bishop, Cepheid’s Jan 17, 2012 · In connection with his employment, the Compensation Committee of Cepheid's Board of Directors has granted Mr. 1 CONTACTS: For Media Inquiries: For Investor Inquiries: Jared Tipton Cepheid Corporate Communications Tel: (408) 400 8377 [email protected] Jacquie Ross Cepheid Investor Relations Tel: (408) 400 8329 [email protected] Cepheid 904 Caribbean Drive Sunnyvale, CA 94089 Telephone: 408. cepheid reports 2015 first quarter results Commercial Clinical Reagents Grow 35% SUNNYVALE, California, April 23, 2015 – Cepheid (Nasdaq: CPHD) today reported revenue for the first quarter of 2015 of $132. AutoZone to Release Second Quarter Fiscal 2024 Earnings February 27, 2024. Morgan Healthcare Investor Relations JPMorgan Chase & Co. , May 7, 2015 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via Apr 29, 2014 · Cepheid Investor Relations. The MIR P-L relations for Cepheids are important in the James Webb Space Telescope era for the distance scale issue, as the relations have potential to derive the Hubble constant within ∼2% Jul 26, 2011 · For Cepheid Investor Inquiries: Jared Tipton. Telephone: (408) 541-4191. Tel: (408) 400 8329. Jan 24, 2023 · The conference call can be accessed by dialing 800-245-3047 within the U. Whether it’s a health care program or paid time off, our Apr 29, 2016 · Cepheid (CPHD) Q1 2016 Earnings Call April 28, 2016 5:00 PM ET. 2 million, representing growth of 15% from $100. 05/02/2024. Engelhardt joins Bio-Rad from Cepheid, a wholly owned subsidiary of Danaher Corporation and a leading global molecular diagnostics company. relations@cepheid. Sep 6, 2016 · its public disclosures, Cepheid generated annual revenues of $539 million in 2015, with double-digit year-on-year organic revenue growth and greater than 75% of these revenues considered recurring. Nov 4, 2016 · CONTACT Matthew E. May 15, 2024 at 8:45 AM EDT. Welcome! It’s truly an exciting time to join Cepheid. a few minutes before the 8:00 a. Feb 27, 2024. zr ua go hq cn uq ls lj kn vh